Recce Pharmaceuticals Statistics

Total Valuation

ASX:RCE has a market cap or net worth of AUD 96.60 million. The enterprise value is 99.40 million.

Market Cap	96.60M
Enterprise Value	99.40M

Important Dates

The last earnings date was Wednesday, May 28, 2025.

Earnings Date	May 28, 2025
Ex-Dividend Date	n/a

Share Statistics

ASX:RCE has 288.37 million shares outstanding. The number of shares has increased by 7.17% in one year.

Current Share Class	288.37M
Shares Outstanding	288.37M
Shares Change (YoY)	+7.17%
Shares Change (QoQ)	+30.98%
Owned by Insiders (%)	35.25%
Owned by Institutions (%)	11.06%
Float	171.91M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	10.07
PB Ratio	-19.37
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-5.54
EV / Sales	10.36
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-7.38

Financial Position

The company has a current ratio of 0.36

Current Ratio	0.36
Quick Ratio	0.24
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	-0.35
Interest Coverage	-12.94

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-217.58%
Return on Invested Capital (ROIC)	-774.31%
Return on Capital Employed (ROCE)	402.13%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	1.98
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -40.57% in the last 52 weeks. The beta is 0.57, so ASX:RCE's price volatility has been lower than the market average.

Beta (5Y)	0.57
52-Week Price Change	-40.57%
50-Day Moving Average	0.31
200-Day Moving Average	0.43
Relative Strength Index (RSI)	48.70
Average Volume (20 Days)	198,537

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ASX:RCE had revenue of AUD 9.59 million and -17.94 million in losses. Loss per share was -0.09.

Revenue	9.59M
Gross Profit	-1.22M
Operating Income	-16.85M
Pretax Income	-17.94M
Net Income	-17.94M
EBITDA	-16.78M
EBIT	-16.85M
Loss Per Share	-0.09

Full Income Statement

Balance Sheet

The company has 1.94 million in cash and 4.74 million in debt, giving a net cash position of -2.80 million or -0.01 per share.

Cash & Cash Equivalents	1.94M
Total Debt	4.74M
Net Cash	-2.80M
Net Cash Per Share	-0.01
Equity (Book Value)	-4.99M
Book Value Per Share	-0.02
Working Capital	-5.39M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -13.42 million and capital expenditures -53,572, giving a free cash flow of -13.47 million.

Operating Cash Flow	-13.42M
Capital Expenditures	-53,572
Free Cash Flow	-13.47M
FCF Per Share	-0.05

Full Cash Flow Statement

Margins

Gross margin is -12.69%, with operating and profit margins of -175.65% and -186.95%.

Gross Margin	-12.69%
Operating Margin	-175.65%
Pretax Margin	-186.95%
Profit Margin	-186.95%
EBITDA Margin	-174.91%
EBIT Margin	-175.65%
FCF Margin	n/a

Dividends & Yields

ASX:RCE does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-7.17%
Shareholder Yield	n/a
Earnings Yield	-18.57%
FCF Yield	-13.94%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ASX:RCE has an Altman Z-Score of -31.2 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-31.2
Piotroski F-Score	3